Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pear Therapeutics, Inc. - Class A Common Stock (NQ: PEAR ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pear Therapeutics, Inc. - Class A Common Stock < Previous 1 2 3 4 5 6 7 Next > Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022 June 08, 2022 From Pear Therapeutics, Inc. Via Business Wire 95 Biggest Movers From Yesterday June 07, 2022 Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II... Via Benzinga Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge June 06, 2022 U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 06, 2022 Via Benzinga Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge June 06, 2022 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. Via Benzinga Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months June 06, 2022 From Pear Therapeutics, Inc. Via Business Wire Earnings Scheduled For May 16, 2022 May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. Via Benzinga 52 Stocks Moving In Monday's Mid-Day Session June 06, 2022 Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users. Via Benzinga Pear Therapeutics to Participate in the Jefferies Healthcare Conference June 02, 2022 From Pear Therapeutics, Inc Via Business Wire 69 Biggest Movers From Friday June 06, 2022 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... Via Benzinga Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting May 24, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022 May 19, 2022 From Pear Therapeutics, Inc. Via Business Wire Chardan Capital Maintains Buy Rating for Pear Therapeutics: Here's What You Need To Know May 17, 2022 Chardan Capital has decided to maintain its Buy rating of Pear Therapeutics (NASDAQ:PEAR) and lower its price target from $16.00 to $13.00. Shares of Pear Therapeutics are trading up 9.75% over the... Via Benzinga 10 Biggest Price Target Changes For Tuesday May 17, 2022 Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday. Via Benzinga Pear Therapeutics Reports First Quarter 2022 Financial Results May 16, 2022 From Pear Therapeutics, Inc. Via Business Wire 90 Biggest Movers From Yesterday May 13, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... Via Benzinga 58 Stocks Moving In Thursday's Mid-Day Session May 12, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. Via Benzinga Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative May 12, 2022 From Pear Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session May 11, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 11, 2022 Via Benzinga Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference May 11, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference May 03, 2022 From Pear Therapeutics, Inc. Via Business Wire 90 Biggest Movers From Yesterday May 10, 2022 Gainers Via Benzinga Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022 May 02, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit April 18, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain April 13, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Participate in Upcoming Investor Conferences April 05, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics Announces Program to Bring Prescription Digital Therapeutics to Patients in Recovery Through a Telehealth Provider Experience April 04, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Participate in Upcoming Investor Event Hosted by Credit Suisse March 31, 2022 From Pear Therapeutics, Inc. Via Business Wire 51 Biggest Movers From Yesterday March 31, 2022 Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.